Tag: Approved

Posted on

New asthma therapy? Approved drugs show promise – Futurity: Research News


Design & Trend

New asthma therapy? Approved drugs show promise
Futurity: Research News
Researchers have identified the potential root cause of asthma and are testing a class of drugs—initially developed to treat osteoporosis—that may reverse symptoms. “Our findings are incredibly exciting,” says Daniela Riccardi, a professor from …
Asthma Could Be Cured Within Five YearsDesign & Trend
Scientists Have Found the Cause of Asthma — and Possibly the CureCosmopolitan.com (blog)
Researchers Possibly Find Root Cause of AsthmaShortNews.com
Pharmaceutical Business Review –Digital Journal
all 6 news articles »

View full post on asthma – Google News

Posted on

First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved – Monthly Prescribing Reference


Monthly Prescribing Reference

First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved
Monthly Prescribing Reference
Teva announced that the Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms. ProAir RespiClick is indicated for the …
FDA clears Teva asthma med (TEVA)Seeking Alpha (registration)
FDA Approves Teva's New Asthma TreatmentArutz Sheva
FDA approves ProAir RespiClick for treatment of acute asthma symptomsHealio
PharmiWeb.com (press release)
all 10 news articles »

View full post on asthma – Google News

Posted on

Once-a-day inhaler for asthma patients is approved for use in Britain – Daily Mail


Daily Mail

Once-a-day inhaler for asthma patients is approved for use in Britain
Daily Mail
Studies show patients find it hard to follow complicated instructions about when to use different inhalers, and that incorrect use often leads to asthma attacks and the need for hospital treatment. Combined reliever and preventative treatments …
GlaxoSmithKline's Relvar Ellipta for asthma and COPD launches in the UKThe Pharma Letter
New once-daily inhaler for COPD and asthmaNursing Times
GlaxoSmithKline in Ware manufactures new treatment for asthma and COPD …Hertfordshire Mercury
StreetInsider.com (subscription)
all 6 news articles »

View full post on asthma – Google News

Posted on

Relvar Ellipta Approved in Japan for Treatment of Asthma – Benzinga

Relvar Ellipta Approved in Japan for Treatment of Asthma
Benzinga
GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma (in cases where …
GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma …NASDAQ
Double asthma approval in Japan lifts SkyePharmaPMLiVE
Asthma drugs head Japan approvalsPharmaTimes
Stock Market Wire –Zacks.com –Reuters
all 19 news articles »

View full post on asthma – Google News

Posted on

Asthma Drug Relva Approved In Europe, Japan, But Not The United States – The Inquisitr

Asthma Drug Relva Approved In Europe, Japan, But Not The United States
The Inquisitr
The United States has already approved the new Asthma drug but it's marketed as Breo in the United States. But US doctors are only allowed to prescribe Breo for chronic obstructive pulmonary disease (COPD) while Europe is recommending the new drug for …
Relvar Ellipta Approved in Japan for Treatment of AsthmaBenzinga
GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma …RTT News
Double asthma approval in Japan lifts SkyePharmaPMLiVE
PharmaTimes –Stock Market Wire –SYS-CON Media (press release)
all 21 news articles »

View full post on asthma – Google News

Posted on

Northwestern Memorial Offers First Non-drug, FDA Approved Therapy for Severe … – NBC Chicago

Northwestern Memorial Offers First Non-drug, FDA Approved Therapy for Severe …
NBC Chicago
Nearly 24 million people in this country suffer from asthma. For most of them, avoiding allergens and taking medications help keep their asthma under control. But for a small group with severe persistent asthma, frequent hospital visits tend to be the …

and more »

View full post on asthma – Google News

Posted on

Asthma and allergies drug Singulair as generic version approved – Health Newstrack


Health Newstrack

Asthma and allergies drug Singulair as generic version approved
Health Newstrack
The U.S. Food and Drug Administration approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Montelukast is in a …
United States : FDA grants approval to TEVA to market generic asthma treatment …Equities.com

all 2 news articles »

View full post on asthma – Google News

Posted on

Generic Singulair Approved – WebMD


MedPage Today

Generic Singulair Approved
WebMD
3, 2012 — The FDA today gave 10 generic drugmakers approval to start making generic versions of Singulair (montelukast sodium), the popular asthma and allergy drug. Singulair, usually taken in the form of tablets, has been a blockbuster drug for Merck.
FDA Greenlights Asthma Drug GenericsMedPage Today
Generic Singulair: Cheaper Forms Of Asthma, Allergy Medication Approved By …Huffington Post
HOT DAMN: Expensive Asthma/Allergy Medication Singulair Goes GenericBabble (blog)
FDA.gov –U.S. News & World Report
all 21 news articles »

View full post on asthma – Google News

Posted on

SkyePharma’s Asthma Drug Finally Approved in Europe – Equities.com

SkyePharma's Asthma Drug Finally Approved in Europe
Equities.com
LONDON – The asthma treatment Flutiform finally won the seal of the European Commission last week, more than 12 years after SkyePharma plc set its sights on what it thought would be the relatively straightforward development of a combination product …
Small caps: Drug OK lifts SkyePharmaFinancial Times

all 2 news articles »

View full post on asthma – Google News